nach oben

Erschienen in:

Open Access 01.12.2020 | COVID-19 | Letter

Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

verfasst von: Fazle Rabbi Chowdhury, Ashraful Hoque, Forhad Uddin Hasan Chowdhury, Md. Ruhul Amin, Abdur Rahim, M. Mujibur Rahman, Rubina Yasmin, Md. Robed Amin, Md. Titu Miah, Md. Abul Kalam, Md. Sayedur Rahman

Erschienen in: Trials | Ausgabe 1/2020

Titel: Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial
verfasst von: Fazle Rabbi Chowdhury
Ashraful Hoque
Forhad Uddin Hasan Chowdhury
Md. Ruhul Amin
Abdur Rahim
M. Mujibur Rahman
Rubina Yasmin
Md. Robed Amin
Md. Titu Miah
Md. Abul Kalam
Md. Sayedur Rahman
Publikationsdatum: 01.12.2020
Verlag: BioMed Central
Schlagwort: COVID-19
Erschienen in: Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04734-z

Springer Medizin

Weitere Artikel der Ausgabe 1/2020

Adaptive interventions for optimizing malaria control: an implementation study protocol for a block-cluster randomized, sequential multiple assignment trial

A technology-enhanced model of care for transitional palliative care versus attention control for adult family caregivers in rural or medically underserved areas: study protocol for a randomized controlled trial

Neurological and psychological mechanisms of the specific and nonspecific effects of acupuncture on knee osteoarthritis: study protocol for a randomized, controlled, crossover trial

Hemoperfusion with HA380 in acute type A aortic dissection patients undergoing aortic arch operation (HPAO): a randomized, controlled, double-blind clinical trial

Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial

A novel method for interpreting survival analysis data: description and test on three major clinical trials on cardiovascular prevention